Related Experiment Videos

Carcinogenicity and mutagenicity testing, then and now

J H Weisburger1

  • 1American Health Foundation, 1 Dana Road, Valhalla, NY, USA. john_weisburger@nymc.edu

Mutation Research
|November 11, 1999
PubMed

Insights

Cancer prevention is a key research goal. New rapid bioassays, focusing on DNA damage, now effectively detect human cancer risks and inform prevention strategies.

Area of Science:

  • Oncology
  • Toxicology
  • Molecular Biology

Background:

  • Cancer remains a leading cause of mortality globally, necessitating advancements in prevention strategies.
  • Early cancer research focused on bioassays of environmental chemicals using animal models.
  • Traditional animal bioassays were lengthy, costly, and limited in accurately assessing human cancer risk.

Observation:

  • Historical bioassays involved applying substances like coal tar to animals (rabbits, mice, rats, hamsters).
  • Investigating the mechanisms of carcinogenesis led to more refined animal testing approaches.
  • Limitations in accurately measuring human cancer risk with existing animal models were identified.

Findings:

  • The realization of DNA as a critical target in carcinogenesis spurred the development of new methods.
  • Rapid bioassays utilizing bacterial and mammalian cell systems were successfully introduced.
  • Current test batteries effectively detect human cancer risks and elucidate underlying mechanisms.

Implications:

  • These advanced bioassays provide a sound basis for effective cancer prevention.
  • Novel approaches enable a deeper understanding of carcinogenesis mechanisms.
  • The shift towards cell-based assays offers more efficient and accurate risk assessment.

Related Concept Videos